Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Cannabis Dependence
NCT01697709Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Oct 2012
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quetiapine in cannabis use disorder (CUD), sponsored by New York State Psychiatric Institute. Started Oct 2012; status: completed.
02
Drugs
quetiapine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT01697709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01697709.